Products & Pipeline
invenious™ connect-and-go infusibles has a strong and growing portfolio
BioQ Pharma’s invenious™ connect-and-go portfolio includes products for post-surgical pain and anesthesia, as well as pipeline assets in sedation, antibiotics, oncology and biosimilars.
The invenious platform could reduce the total cost of care for the provider.

Ropivacaine Readyfusor* and invenious™/propofol are two examples of infusible products already using invenious™ connect-and-go technology.
Ropivacaine Readyfusor
The Ropivacaine Readyfusor infusion pharmaceutical is pre-filled and is intended to provide a safer, more efficient solution (at a lower total cost) than fillable pain pumps. Our Ropivacaine Readyfusor pharmaceutical is applicable to surgical procedures conducted in hospitals and surgery centers.
BioQ Pharma markets Ropivacaine Readyfusor through a variety of partners worldwide.

invenious™/propofol
Propofol is one of the world’s most commonly used procedural anesthetic agents. invenious™/propofol features programmable flow and bolus capabilities. Our ready-to-use invenious™/propofol pharmaceutical presentation has been designed with the intent to help providers increase patient throughput, while improving safety and sterility for patients.
BioQ Pharma is marketing invenious™/propofol through our worldwide commercial partners.
